4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-056355
EVP, COO, Head of Commercial sold 4,960 shares at $22.64 ($112,294)
- EVP, COO, Head of Commercial acquired 9,912 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-11-17 | Option exercise | +4,956 | 30,397 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-11-17 | Option exercise | +4,956 | 35,353 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-11-20 | Sale | −4,960 | $22.64 | $112,294 | 30,393 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-11-17 | Option exercise · Restricted Stock Units | −4,956 | 19,826 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-11-17 | Option exercise · Restricted Stock Units | −4,956 | 19,826 | D | ||
| Open-market sales · 4,960 sh · avg $22.64 · $112,294 | |||||||
Loading xslF345X05/doc4.xml…